Drug monitoring of lamotrigine increases drug safety of concomitant use with valproate

被引：0
|
作者：
Greiner, C. [1 ]
Bader, W. [1 ]
Melchner, D. [1 ]
Haen, E. [1 ]
机构：
[1] Univ Regensburg, Klin Pharmakol Klin & Poliklin Psychiat, D-8400 Regensburg, Germany
来源：
DRUG SAFETY | 2006年 / 29卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
58
引用
收藏
页码：942 / 942
页数：1
相关论文
共 50 条
  • [31] Lamotrigine in pregnancy: Clearance, therapeutic drug monitoring, and seizure frequency
    Pennell, P. B.
    Peng, L.
    Newport, D. J.
    Ritchie, J. C.
    Koganti, A.
    Holley, D. K.
    Newman, M.
    Stowe, Z. N.
    NEUROLOGY, 2008, 70 (22) : 2130 - 2136
  • [32] DRUG LEVELS OF OTHER ANTIEPILEPTIC DRUGS DURING CONCOMITANT TREATMENT WITH SODIUM VALPROATE
    FLACHS, H
    GRAM, L
    WURTZJORGENSEN, A
    PARNAS, J
    EPILEPSIA, 1979, 20 (02) : 187 - 187
  • [33] Lamotrigine/valproate-semisodiumCongenital malformations following drug-drug interaction during in-utero exposure: case report
    Reactions Weekly, 2023, 1978 (1) : 217 - 217
  • [34] Drug interactions between lamotrigine and psychoactive drugs - Evidence from a therapeutic drug monitoring service
    Reimers, A
    Skogvoll, E
    Sund, JK
    Spigset, A
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2005, 25 (04) : 342 - 348
  • [35] Therapeutic drug monitoring as a tool for assessment of drug interaction between lamotrigine and other antiepileptic drugs
    Ben Sassi, M.
    Gaies, E.
    Salouage, I.
    Charfi, R.
    Jebabli, N.
    El Jebari, H.
    Klouz, A.
    Daghfous, R.
    Trabelsi, S.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2018, 32 : 74 - 74
  • [36] RATIONAL USE OF VALPROATE - INDICATIONS AND DRUG REGIMEN IN EPILEPSY
    LOISEAU, P
    EPILEPSIA, 1984, 25 : S65 - S72
  • [37] POSSIBLE DRUG-DRUG INTERACTION BETWEEN QUETIAPINE AND LAMOTRIGINE - EVIDENCE FROM A SWEDISH THERAPEUTIC DRUG MONITORING DATABASE
    Andersson, M. L.
    Bjorkhem-Bergman, L.
    Lindh, J. D.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 40 - 41
  • [38] Lack of clinically significant pharmacokinetic drug interactions between RWJ-333369 and valproate or lamotrigine
    Chien, SC
    Yao, CP
    Mertens, A
    Verhaeghe, T
    Solanki, B
    Doose, D
    Novak, G
    EPILEPSIA, 2005, 46 : 173 - 173
  • [39] Timing of Concomitant Drug Use in Pharmacoepidemiological Studies
    Abbing-Karahagopian, Victoria
    Gardarsdottir, Helga
    Souverein, Patrick C.
    Klungel, Olaf H.
    Leufkens, Bert G. M.
    Egberts, Toine C. G.
    De Bruin, Marieke L.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 423 - 423
  • [40] Optimizing the Use of State Prescription Drug Monitoring Programs for Public Safety
    Green, Sherry L.
    Pfenning, Stacey
    JOURNAL OF NURSING REGULATION, 2015, 6 (03) : 4 - 10
12345